Madrigal Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Madrigal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Madrigal Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Madrigal Pharmaceuticals by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $182M | 589k | 308.57 |
2024-09-30 | $156M | 734k | 212.22 |
2024-06-30 | $241M | 859k | 280.21 |
2024-03-31 | $215M | 803k | 267.04 |
2023-12-31 | $90M | 389k | 231.38 |
2023-09-30 | $25M | 170k | 146.04 |
2023-06-30 | $13M | 55k | 231.01 |
2023-03-31 | $11M | 47k | 242.28 |
2022-12-31 | $16M | 55k | 290.24 |
2022-03-31 | $4.4M | 45k | 98.11 |
2021-12-31 | $4.1M | 49k | 84.74 |
2021-09-30 | $4.6M | 58k | 79.79 |
2021-06-30 | $7.4M | 76k | 97.41 |
2021-03-31 | $10M | 86k | 116.97 |
2020-12-31 | $19M | 171k | 111.17 |
2020-09-30 | $21M | 176k | 118.73 |
2020-06-30 | $16M | 144k | 113.25 |
2020-03-31 | $3.1M | 47k | 66.76 |
2019-12-31 | $4.3M | 47k | 91.10 |
2019-09-30 | $12M | 143k | 86.22 |
2019-06-30 | $24M | 231k | 104.81 |
2019-03-31 | $33M | 262k | 125.26 |
2018-12-31 | $29M | 261k | 112.72 |
2018-09-30 | $107M | 501k | 214.13 |
2018-06-30 | $159M | 568k | 279.69 |
2018-03-31 | $22M | 186k | 116.79 |